Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study

Aydin Y., Atis A., Kaleli S., Uludag S., Goker N.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.150, sa.2, ss.203-206, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 150 Sayı: 2
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1016/j.ejogrb.2010.02.024
  • Dergi Adı: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.203-206
  • Anahtar Kelimeler: Mastalgia, Premenstrual syndrome, Prolactin, Breast, Pain, CYCLICAL MASTALGIA, PARKINSONS-DISEASE, DOPAMINE AGONISTS, MANAGEMENT, TOREMIFENE, TAMOXIFEN, METAANALYSIS, MULTICENTER, TRIAL, WOMEN
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objective: To compare the effectiveness and side effects of cabergoline with bromocriptine for the symptomatic treatment of cyclic mastalgia as a part of the premenstrual syndrome.